Bioavailability of cefuroxime axetil suspension in healthy volunteers

被引：0
|
作者：
Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100083, China [1 ]
机构：
来源：
Chinese Pharmaceutical Journal | 2001年 / 36卷 / 09期
关键词：
3 This work was supported by National Cancer Programme (Grant 2111) and Polish Academy of Science (Grant 10.5) Abbreviations: FeR = receptor for Fc part of IgG; EAhu = human erythrocytes group «0» Rh+ (D) coated with human anti-D IgG antibody; ADCC = antibody-dependent cellular cytotoxicity; PBM = peripheral blood mononuclear cells; AC = adherent cells; EAhu = RFC cells forming rosettes with EAhu complexes; MEM = minimum essential medium; 51Cr = labelled sodium chromate; SE. = standard error;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
5
引用
收藏
页码：609 / 611
相关论文
共 50 条
  • [1] Effects of Amlodipine on the Oral Bioavailability of Cephalexin and Cefuroxime Axetil in Healthy Volunteers
    Ding, Yi
    Liu, WenXing
    Jia, YanYan
    Lu, ChengTao
    Jin, Xin
    Yang, Jing
    Zhu, YanRong
    Yang, Lin
    Song, Ying
    Ding, LiKun
    Wen, AiDong
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (01): : 82 - 86
  • [2] Comparative bioavailability of cefuroxime axetil suspension formulations administered with food in healthy subjects
    Mendes, Gustavo D.
    Borges, Andre
    Val, Ligia de Cassia
    Patni, Anil K.
    Reyar, Simrit
    Monif, Tausif
    Sereno, Daiene
    Orellana, Ana Maria M.
    De Nucci, Gilberto
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2010, 60 (02): : 101 - 105
  • [3] THE EFFECT OF CEFUROXIME AXETIL ON THE FECAL FLORA OF HEALTHY-VOLUNTEERS
    LEIGH, DA
    WALSH, B
    LEUNG, A
    TAIT, S
    PEATEY, K
    HANCOCK, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 (02) : 261 - 268
  • [4] BIOAVAILABILITY OF CEFUROXIME AXETIL FORMULATIONS
    DONN, KH
    JAMES, NC
    POWELL, JR
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (06) : 842 - 844
  • [5] Cefuroxime axetil for oral suspension
    Heller, Marissa
    JOURNAL OF DRUGS IN DERMATOLOGY, 2008, 7 (03) : 308 - 308
  • [6] Comparative bioavailability study of cefuroxime axetil (equivalent to 500 mg cefuroxime/tablet) tablets (Zednad® versus Zinnat®) in healthy male volunteers
    Asiri, Y. A.
    Al-Hadiya, B. M.
    Kadi, A. A.
    Al-Khamis, K. I.
    Mowafy, H. A.
    El-Sayed, Y. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (09) : 571 - 576
  • [7] CEFUROXIME AXETIL ORAL SUSPENSION
    HARRIS, AM
    RAUCH, AM
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (09) : 838 - 838
  • [8] COMPARATIVE INVESTIGATIONS ON THE BIOAVAILABILITY OF CEFUROXIME AXETIL
    KEES, F
    LUKASSEK, U
    NABER, KG
    GROBECKER, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1991, 41-2 (08): : 843 - 846
  • [9] Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers
    Nix, DE
    Symonds, WT
    Hyatt, JM
    Wilton, JH
    Teal, MA
    Reidenberg, P
    Affrime, MB
    PHARMACOTHERAPY, 1997, 17 (01): : 121 - 125
  • [10] EFFECT OF DOSE AND FOOD ON THE BIOAVAILABILITY OF CEFUROXIME AXETIL
    FINN, A
    STRAUGHN, A
    MEYER, M
    CHUBB, J
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1987, 8 (06) : 519 - 526
12345